Rocket Pharmaceuticals Inc. (RCKT)
NASDAQ · Healthcare
Rocket Pharmaceuticals Inc. Operating Income 2016–2025
Rocket Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Rocket Pharmaceuticals Inc. operating income for the quarter ending March 31, 2026 was -48.5 M, a 24.66% decrease year-over-year.
- Rocket Pharmaceuticals Inc. operating income for the twelve months ending March 31, 2026 was -236.3 M, a 14.37% decrease year-over-year.
- Rocket Pharmaceuticals Inc. annual operating income for 2025 was -231.7 M, a 15.17% decrease from 2024.
- Rocket Pharmaceuticals Inc. annual operating income for 2024 was -273.2 M, a 5.22% increase from 2023.
- Rocket Pharmaceuticals Inc. annual operating income for 2023 was -259.7 M, a 15.74% increase from 2022.
- Rocket Pharmaceuticals Inc. annual operating income for 2022 was -224.3 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Rocket Pharmaceuticals Inc. Operating Income — FAQ
Rocket Pharmaceuticals Inc. (RCKT) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Rocket Pharmaceuticals Inc.'s operating income?
Rocket Pharmaceuticals Inc. (RCKT) reported operating income of -$232M for fiscal 2025.
Where can I see RCKT's operating income history?
The chart and table above show Rocket Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.